1. 樊嘉 中国 复旦大学上海医学院 中国科学院院士 PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti-PD-1 Immunotherapy
2. 刘允怡 中国 香港中文大学 中国科学院院士 Development and validation of glycolysis-related prognostic score for prediction of prognosis and ch..
3. Ali, Simak 英国 Imperial College London Selective inhibition of CDK9 in triple negative breast cancer
4. Richard,Iggo 法国 Universite de Bordeaux PRES Selective inhibition of CDK9 in triple negative breast cancer
5. Tilley, Wayne D. 澳大利亚 University of Adelaide Selective inhibition of CDK9 in triple negative breast cancer
6. Sahoo, Sanjeeb Kumar 印度 Nanomed Laboratory,Indian Piperlongumine based nanomedicine impairs glycolytic metabolism in triple negative breast cancer ste..
7. 周俭 中国 复旦大学上海医学院 PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti-PD-1 Immunotherapy
8. Joachim,Fandrey 德国 University of Duisburg-Essen Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor Improves Leukocyte Energy Metabolism in Heredi..
9. Giovanni,Blandino 意大利 REGINA ELENA Institute Cancer Research Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Brea..
10. Olivier,Hermine 法国 University of PARIS 05 Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse ..
11. Didier,Bouscary 法国 University of PARIS 05 Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse ..
12. David,Marin 美国 University of Texas MD Anderson Cancer Center Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by c..
13. Richard E,Champlin 美国 University of Texas MD Anderson Cancer Center Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by c..
14. Elizabeth J,Shpall 美国 University of Texas MD Anderson Cancer Center Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by c..
15. Ken,Chen 美国 University of Texas MD Anderson Cancer Center Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by c..
16. Katayoun,Rezvani 美国 University of Texas MD Anderson Cancer Center Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by c..
17. Trevor W,Stone 英国 University of Oxford Interactions of IDO and the Kynurenine Pathway with Cell Transduction Systems and Metabolism at the ..
18. Williams, Richard 英国 Kennedy Institute of Rheumatology Interactions of IDO and the Kynurenine Pathway with Cell Transduction Systems and Metabolism at the ..
19. Utkan,Demirci 美国 Stanford University Methods to Evaluate Changes in Mitochondrial Structure and Function in Cancer
20. 杨安钢 中国 空军军医大学 Targeting the E3 ligase NEDD4 as a novel therapeutic strategy for IGF1 signal pathway-driven gastric..